Literature DB >> 12750986

Increased c-Met tyrosine kinase expression in segmental renal dysplasia.

Valeria Solari1, Boris Chertin, Hideki Shima, Prem Puri.   

Abstract

Renal dysplasia (RD) is a disorganized development of renal parenchyma that results in a deficit of functional renal tissue. It has been suggested in the animal model that increased expression of HGF receptor, c-Met tyrosine kinase in the epithelial cells during kidney development may induce a growth of dysplastic epithelia and result in RD. The aim of this study was to investigate the immunoreactivity of c-Met tyrosine kinase in the dysplastic kidney in order to further understand the pathogenesis of RD. Specimens of dysplastic upper pole kidney were obtained from 19 patients during upper pole partial nephrectomy for non-functioning upper moiety of duplex kidney. In the dysplastic kidney, there was strong c-Met immunoreactivity in the epithelium of primitive tubules. In contrast, c-Met immunoreactivity was barely detectable in the normal kidney. Markedly increased expression of HGF receptor, c-Met tyrosine kinase in renal dysplasia suggests that HGF may be involved in the development of renal dysplasia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12750986     DOI: 10.1007/s00467-003-1124-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  7 in total

1.  Hepatocyte growth factor.

Authors:  G K Michalopoulos; R Zarnegav
Journal:  Hepatology       Date:  1992-01       Impact factor: 17.425

2.  Expression of hepatocyte growth factor/scatter factor and its receptor, MET, suggests roles in human embryonic organogenesis.

Authors:  M Kolatsi-Joannou; R Moore; P J Winyard; A S Woolf
Journal:  Pediatr Res       Date:  1997-05       Impact factor: 3.756

3.  Increased expression of fibroblast growth factors in segmental renal dysplasia.

Authors:  H Shima; H Tazawa; P Puri
Journal:  Pediatr Surg Int       Date:  2000       Impact factor: 1.827

4.  Potential biological role of transforming growth factor-beta1 in human congenital kidney malformations.

Authors:  S P Yang; A S Woolf; H T Yuan; R J Scott; R A Risdon; M J O'Hare; P J Winyard
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

5.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.

Authors:  D P Bottaro; J S Rubin; D L Faletto; A M Chan; T E Kmiecik; G F Vande Woude; S A Aaronson
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

Review 6.  Structure and function of hepatocyte growth factor.

Authors:  T Nakamura
Journal:  Prog Growth Factor Res       Date:  1991

7.  Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros.

Authors:  A S Woolf; M Kolatsi-Joannou; P Hardman; E Andermarcher; C Moorby; L G Fine; P S Jat; M D Noble; E Gherardi
Journal:  J Cell Biol       Date:  1995-01       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.